Navigation Links
Increased SVR and Decreased Adverse Events Reported in Final Results of Phase 3 Study on Telaprevir
Date:11/1/2010

vents leading to treatment discontinuation occurred in 7 percent of patients in the arm receiving telaprevir combination treatment for 12 weeks, 8 percent in telaprevir for 8 weeks, and 4 percent in the peginterferon alfa-2a and ribavirin arm.

Abstract title:

Telaprevir in Combination with Peginterferon and Ribavirin in Genotype 1 HCV Treatment-Naive Patients: Final Results of Phase 3 ADVANCE Study

About the AASLD

AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. This year's Liver Meeting®, held in Boston, Massachusetts, October 29-November 2, will bring together more than 7,500 researchers from 55 countries.

A pressroom will be available from October 30 at the annual meeting. For copies of abstracts and press releases, or to arrange for pre-conference research interviews contact Gregory Bologna at 703-299-9766. To pre-register, call Ann Haran at 703-299-9766.

Press releases and all abstracts are available online at www.aasld.org.

Quote from Dr. Jacobson: "This phase 3 trial confirms previous findings that telaprevir confers  higher rates of viral cure in patients with the highly prevalent genotype 1 when compared with the current standard of care, with the added advantage of a  shorter total duration of treatment  in the majority of patients.  Although rash and anemia were more common with telaprevir, treatment discontinuation due to side effects was very infrequent and side effects attributable to the drug are reversible.  This study, along with others on protease inhibitors at this year's meeting, heralds an  exciting new era in HCV therapy in which increasing numbers of patients will be cured and spared the life-threatening risks of advanced liver disease."Media Contact: Gregory Bologna703/299-9766gbologna@aasld.o
'/>"/>

SOURCE American Association for the Study of Liver Diseases (AASLD)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods, According to Kline
2. FDA: Possible Increased Risk of Thigh Bone Fracture With Bisphosphonates
3. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
4. Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million
5. Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
6. Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market
7. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
8. Medical Affairs Budget & Staffing Remain Top Challenges Despite Increased Funding
9. HealthWarehouse.com Now Offers Over 1,000 Medications Under $25 Bringing Increased Affordability to Consumers
10. APC Group, Inc. Reports Fiscal Year End Sales Revenues Increased 30% for 2009
11. New Study Links dLife to Increased Rx Drug Usage Among Diabetes Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  In part four ... leverage a hospital pharmacy as a strategic asset, ... practice leader for Cardinal Health,s Innovation Delivery Solutions business, ... can benefit both hospitals and patients. "Every ... one part of their job in a value-based healthcare ...
(Date:8/29/2014)... August 29, 2014 Pixcelldata, the ... software has announced a major new deal with Dutch ... renowned pathology expert, Dr. Marius Nap . ... 26th European Congress of Pathology which is taking placing ... Arena, London where Pixcelldata will ...
(Date:8/28/2014)... Reportlinker.com announces that a new market ... North America Aesthetic Lasers and Energy Devices ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North America Aesthetic Lasers ... Summary GlobalData,s new report, "North America Aesthetic ... provides key market data on the North America ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
... Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that ... upcoming investor conferences:   Kathryn Falberg, the ... ROTH 23rd Annual OC Growth Stock Conference in Dana Point, ... Time Bruce Cozadd, the company,s chairman and chief executive ...
... DUBLIN, March 8, 2011 Warner Chilcott plc (Nasdaq: ... of 25 million of its ordinary shares by certain ... Bain Capital Partners, J.P. Morgan Partners (advised by CCMP ... of the Company,s senior management. The offering is being ...
Cached Medicine Technology:Warner Chilcott Announces Secondary Equity Offering 2Warner Chilcott Announces Secondary Equity Offering 3Warner Chilcott Announces Secondary Equity Offering 4
(Date:8/29/2014)... (PRWEB) August 29, 2014 Healthpointe is ... Chuang, has joined their practice. Dr. Chuang garners extensive ... specializes in minimally-invasive arthroscopic and reconstructive treatments of the ... for patients with general and sports-related orthopedic needs. ... the medical field. As an Orange County native, he ...
(Date:8/29/2014)... based on administering antidepressants for acute and chronic ... are needed to determine whether these drugs should ... basis., Dr. Ian Gilron, a professor and director ... Anesthesiology, and his team of seven researchers reviewed ... antidepressants for pain relief post-surgery would work more ...
(Date:8/29/2014)... Colo. (Sept. 2, 2014) A team of scientists ... reported the breakthrough discovery of a process to expand ... These findings could have implications that extend beyond cancer, ... autoimmune diseases., In an article published Aug. ... Charles C. Gates Center for Regenerative Medicine and Stem ...
(Date:8/29/2014)... 29, 2014, 2 PM US Eastern Time)The current ... inject antibodies, commonly produced in animals, to neutralize ... from safety to difficulties in developing, producing and ... New research led by Charles Shoemaker, Ph.D., professor ... Health at the Cummings School of Veterinary Medicine ...
(Date:8/29/2014)... research group of Dr. John Lewis at the University of ... ON) has confirmed that "invadopodia" play a key role in ... Reports , shows preventing these tentacle-like structures from forming can ... in 5 Canadians will develop cancer in their lifetime, and ... In 2014, it,s estimated that nine Canadians will die of ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Honored to Induct Orthopedic Surgeon into Their Team 2Health News:Antidepressants show potential for postoperative pain 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Mice study shows efficacy of new gene therapy approach for toxin exposures 2Health News:Preventing cancer from forming 'tentacles' stops dangerous spread 2
... in police custody is standard operating procedure for many ... idea that using a Taser could lead to a ... final results of a study conducted by emergency medicine ... Medical Center showed no lasting effects of the Taser ...
... Some ethnic minorities could be twice as likely as ... prayer to medication for treating depression , according ... Asians who took the survey were skeptical about the ... to antidepressants, according to Jane Givens, M.D., of Boston ...
... liberated woman is certainly looking for ways and means of ... available is a bit complicated . ,Offering a ... Lybrel and the Food and Drug Administration (FDA) is expected ... meant to evoke "liberty," would be the fourth new oral ...
... traditional Indigenous land owners could help improve the overall ... ,Over the past 30 years, there has ... people who regain ownership and control of their traditional ... Research Fellow at the Jumbunna Indigenous House of Learning, ...
... the risk of diabetes in the Indigenous population, say ... Robyn McDermott, Pro-vice Chancellor of the Division of Health ... while clinical care of adults with diabetes has improved, ... ,The results, published in the latest Medical Journal ...
... the myth of big hydropower projects being clean, a ... the country are accountable for at least 19 ... ,According to the study, Indian dams are larger ... large dams could be around 33.5 million tonnes (MT) ...
Cached Medicine News:Health News:Healthy Humans Not Harmed By Taser 2Health News:Minorities Prefer Counseling and Prayer to Drugs for Treating Depression 2Health News:New Pill to Suppress Menstrual Bleeding Indefinitely 2Health News:New Pill to Suppress Menstrual Bleeding Indefinitely 3Health News:Health Benefits Of Traditional Land Ownership 2
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... The Vidiera NsD Nucleic Sample Detection ... acids, post amplification. The new platform ... by capillary electrophoresis (CE), with software features ... and flexibility. Vidiera NsD has the ...
Invacare 5 Oxygen Concentrator, 230 VAC - Intl....
... PLUS CONCENTRATOR ANALYZER Now there is one ... parameters necessary for performing concentrator checks. Introducing ... efficient and cost-effective analyzer designed with technicians ... flow rate (L-min), and patient outlet pressure ...
Medicine Products: